Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis

Journal of the American Academy of Dermatology

Volumn 69, Issue 6, 2013, Pages 938-946

  Orgaz Molina, Jacinto ^a   Magro Checa, Cesar ^b   Rosales Alexander, José Luis ^b   Arrabal Polo, Miguel A ^c   Buendía Eisman, Agustín ^c   Raya Alvarez, Enrique ^b   Arias Santiago, Salvador ^a,c  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b San Cecilio University Hospital   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

glucose; lipids; psoriasis; psoriatic arthritis; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSORIASIS; PSORIATIC ARTHRITIS; VITAMIN BLOOD LEVEL;

25-(OH)D; 25-HYDROXYVITAMIN D; BMI; BODY MASS INDEX; GLUCOSE; HDL; HIGH-DENSITY LIPOPROTEIN; LDL; LIPIDS; LOW-DENSITY LIPOPROTEIN; METHOTREXATE; MTX; PSORIASIS; PSORIATIC ARTHRITIS; TNF; TUMOR NECROSIS FACTOR; VITAMIN D;

ADULT; ARTHRITIS, PSORIATIC; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE; HUMANS; LIPID METABOLISM; MALE; MIDDLE AGED; PSORIASIS; VITAMIN D;

EID: 84887989424     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.08.007     Document Type: Article

References (40)

1. A. Menter, C.E. Griffiths, P.W. Tebbey, E.J. Horn, and W. Sterry Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community J Eur Acad Dermatol Venereol 24 2010 1371 1377
2. S. Arias-Santiago, J. Orgaz-Molina, L. Castellote-Caballero, M.Á. Arrabal-Polo, S. García-Rodriguez, and R. Perandrés-López Atheroma plaque, metabolic syndrome and inflammation in patients with psoriasis Eur J Dermatol 22 2012 337 344
3. S. Garcia-Rodriguez, S. Arias-Santiago, R. Perandrés-López, L. Castellote, E. Zumaquero, and P. Navarro Increased gene expression of Toll-like receptor 4 on peripheral blood mononuclear cells in patients with psoriasis J Eur Acad Dermatol Venereol 27 2013 242 250
4. S. Arias-Santiago, M.T. Gutiérrez-Salmerón, A. Buendía-Eisman, M.S. Girón-Prieto, and R. Naranjo-Sintes Lipid levels in women with androgenetic alopecia Int J Dermatol 49 2010 1340 1342
5. S. Arias-Santiago, A. Buendía-Eisman, J. Aneiros-Fernández, M.S. Girón-Prieto, M.T. Gutiérrez-Salmerón, and V.G. Mellado Cardiovascular risk factors in patients with lichen planus Am J Med 124 2011 543 548
6. D.R. Brenner, P. Arora, B. Garcia-Bailo, T.M. Wolever, H. Morrison, and A. El-Sohemy Plasma vitamin D levels and risk of metabolic syndrome in Canadians Clin Invest Med 34 2011 E377
7. H. Dobnig, S. Pilz, H. Scharnagl, W. Renner, U. Seelhorst, and B. Wellnitz Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality Arch Intern Med 168 2008 1340 1349
8. T.L. Clemens, K.P. Garrett, X.Y. Zhou, J.W. Pike, M.R. Haussler, and D.W. Dempster Immunocytochemical localization of the 1,25-dihydroxyvitamin-D3 receptor in target cells Endocrinology 122 1988 1224 1230
9. M.R. Haussler, G.K. Whitfield, C.A. Haussler, J.C. Hsieh, P.D. Thompson, and S.H. Selznick The nuclear vitamin D receptor: biological and molecular regulatory properties revealed J Bone Miner Res 13 1998 325 349
10. W.E. Stumpf, M. Sar, S.A. Clark, and H.F. DeLuca Brain target sites for 1,25-dihydroxyvitamin D3 Science 215 1982 1403 1405
11. D. Zehnder, R. Bland, M.C. Williams, R.W. McNinch, A.J. Howie, and P.M. Stewart Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase J Clin Endocrinol Metab 86 2001 888 894
12. P. Gisondi, M. Rossini, A. Di Cesare, L. Idolazzi, S. Farina, and G. Beltrami Vitamin D status in patients with chronic plaque psoriasis Br J Dermatol 166 2012 505 510
13. J. Orgaz-Molina, A. Buendía-Eisman, M.A. Arrabal-Polo, J.C. Ruiz, and S. Arias-Santiago Deficiency of serum concentration of 25-hydroxyvitamin D in psoriatic patients: a case-control study J Am Acad Dermatol 67 2012 931 938
14. A. Perez, R. Raab, T.C. Chen, A. Turner, and M.F. Holick Safety and efficacy of oral calcitriol (1,25-dihydroxyvitamin D) for the treatment of psoriasis Br J Dermatol 134 1996 1070 1078
15. J. Gaál, G. Lakos, P. Szodoray, J. Kiss, I. Horváth, and E. Horkay Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study Acta Derm Venereol 89 2009 140 144
16. A. Emaus, J. Degerstrøm, T. Wilsgaard, B.H. Hansen, C.M. Dieli-Conwright, and A.S. Furberg Does a variation in self-reported physical activity reflect variation in objectively measured physical activity, resting heart rate, and physical fitness? Results from the Tromso study Scand J Public Health 38 Suppl 2010 105 118
17. R. Zhang, and D.P. Naughton Vitamin D in health and disease: current perspectives Nutr J 9 2010 65
18. J.A. Husted, A. Thavaneswaran, V. Chandran, L. Eder, C.F. Rosen, and R.J. Cook Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis Arthritis Care Res 63 2011 1729 1735
19. L. Eder, S. Shanmugarajah, A. Thavaneswaran, V. Chandran, C.F. Rosen, and R.J. Cook The association between smoking and the development of psoriatic arthritis among psoriasis patients Ann Rheum Dis 71 2012 219 224
20. L.D. Carbone, E.W. Rosenberg, E.A. Tolley, M.F. Holick, T.A. Hughes, and M.A. Watsky 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation Metabolism 57 2008 741 748
21. E. Liu, J.B. Meigs, A.G. Pittas, N.M. McKeown, C.D. Economos, and S.L. Booth Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults J Nutr 139 2009 329 334
22. P. Karhapää, J. Pihlajamäki, I. Pörsti, M. Kastarinen, J. Mustonen, and O. Niemelä Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidemias J Intern Med 268 2010 604 610
23. M.K. Shea, E.J. Benjamin, J. Dupuis, J.M. Massaro, P.F. Jacques, and R.B. D'Agostino Sr Genetic and non-genetic correlates of vitamins K and D Eur J Clin Nutr 63 2009 458 464
24. D. Hunter, M. De Lange, H. Snieder, A.J. MacGregor, R. Swaminathan, and R.V. Thakker Genetic contribution to bone metabolism, calcium excretion, and vitamin D and parathyroid hormone regulation J Bone Miner Res 16 2001 371 378
25. T.J. Wang, F. Zhang, J.B. Richards, B. Kestenbaum, J.B. van Meurs, and D. Berry Common genetic determinants of vitamin D insufficiency: a genome-wide association study Lancet 376 2010 180 188
26. G.S. Tint, M. Irons, E.R. Elias, A.K. Batta, R. Frieden, T.S. Chen Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome N Engl J Med 330 1994 107 113
27. N.M. Al-Daghri, K.M. Alkharfy, Y. Al-Saleh, O.S. Al-Attas, M.S. Alokail, and A. Al-Othman Modest reversal of metabolic syndrome manifestations with vitamin D status correction: a 12-month prospective study Metabolism 61 2012 661 666
28. I. Barchetta, F. Angelico, M. Del Ben, M.G. Baroni, P. Pozzilli, and S. Morini Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes BMC Med 9 2011 85
29. N.G. Forouhi, J. Luan, A. Cooper, B.J. Boucher, and N.J. Wareham Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000 Diabetes 57 2008 2619 2625
30. G. Grimnes, N. Emaus, R.M. Joakimsen, Y. Figenschau, T. Jenssen, and I. Njølstad Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up Diabet Med 27 2010 1107 1115
31. J.A. Johnson, J.P. Grande, P.C. Roche, and R. Kumar Immunohistochemical localization of the 1,25(OH)2D3 receptor and calbindin D28k in human and rat pancreas Am J Physiol 267 1994 E356 E360
32. R. Bland, D. Markovic, C.E. Hills, S.V. Hughes, S.L. Chan, and P.E. Squires Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in pancreatic islets J Steroid Biochem Mol Biol 89-90 2004 121 125
33. C. Cade, and A.W. Norman Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo Endocrinology 119 1986 84 90
34. L.J. Persson, M. Aanerud, P.S. Hiemstra, J.A. Hardie, P.S. Bakke, and T.M. Eagan Chronic obstructive pulmonary disease is associated with low levels of vitamin D PLoS One 7 2012 e38934
35. D.L. Kamen, G.S. Cooper, H. Bouali, S.R. Shaftman, B.W. Hollis, and G.S. Gilkeson Vitamin D deficiency in systemic lupus erythematosus Autoimmun Rev 5 2006 114 117
36. C. Brot, N.R. Jorgensen, and O.H. Sorensen The influence of smoking on vitamin D status and calcium metabolism Eur J Clin Nutr 53 1999 920 926
37. J. Oh, S. Weng, S.K. Felton, S. Bhandare, A. Riek, and B. Butler 1,25(OH)2 vitamin d inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus Circulation 120 2009 687 698
38. I. Naharci, E. Bozoglu, N. Kocak, S. Doganci, H. Doruk, and M. Serdar Effect of vitamin D on insulin sensitivity in elderly patients with impaired fasting glucose Geriatr Gerontol Int 12 2012 454 460
39. D.Y. Chen, H.M. Chih, J.L. Lan, H.Y. Chang, W.W. Chen, and E.P. Chiang Blood lipid profiles and peripheral blood mononuclear cell cholesterol metabolism gene expression in patients with and without methotrexate treatment BMC Med 9 2011 4
40. C. Popa, M.G. Netea, T. Radstake, Meer J.W. Van der, A.F. Stalenhoef, and Riel P.L. van Influence of anti-tumor necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis Ann Rheum Dis 64 2005 303 305